The 4 bullish analyst ratings in the last quarter indicate a positive outlook for Repare Therapeutics. The average 12-month price target of $23.0, which is up 27.78% from the previous average, suggests that analysts expect the stock price to rise in the short term. This positive sentiment is likely to have a positive impact on the stock price.